Consistently, a recent pan-cancer analysis found >2-fold ALPP overexpression in multiple solid tumors (e.g., ovarian, endometrial carcinomas) relative to normal tissues, and linked high ALPP levels to aggressive disease courses in at least one cancer type (pancreatic adenocarcinoma) 22. This evidence concerns the gene ALPP and endometrial carcinoma.